Chapter 5.6 The genetics of human anxiety disorders

Handbook of Behavioral Neuroscience

Volumn 17, Issue , 2008, Pages 475-510

  Maron, Eduard ^a   Hettema, John M ^b   Shlik, Jakov ^c  

^a UNIVERSITY OF TARTU   (Estonia)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c ROYAL OTTAWA HEALTH CARE GROUP   (Canada)

Author keywords

anxiety disorder; association; family; genetic; linkage study; pharmacogenetic; polymorphism; twin

Indexed keywords

EID: 67649979487     PISSN: 15697339     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1569-7339(07)00022-7     Document Type: Review

References (261)

1. Alsene K., Deckert J., Sand P., and de W.H. Association between A2a receptor gene polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology 28 (2003) 1694-1702
2. Alsobrook J.P., Zohar A.H., Leboyer M., Chabane N., Ebstein R.P., and Pauls D.L. Association between the COMT locus and obsessive-compulsive disorder in females but not males. Am. J. Med. Genet. 114 (2002) 116-120
3. Andrews G., Stewart G., Allen R., and Henderson A.S. The genetics of six neurotic disorders: a twin study. J. Affect. Disord. 19 (1990) 23-29
4. Armengol L., Gratacos M., Pujana M.A., Ribases M., Martin-Santos R., and Estivill X. 5′ UTR-region SNP in the NTRK3 gene is associated with panic disorder. Mol. Psychiatry 7 (2002) 928-930
5. Arnold P.D., Rosenberg D.R., Mundo E., Tharmalingam S., Kennedy J.L., and Richter M.A. Association of a glutamate (NMDA) subunit receptor gene (GRIN2B) with obsessive-compulsive disorder: a preliminary study. Psychopharmacology 174 (2004) 530-538
6. Arnold P.D., Sicard T., Burroughs E., Richter M.A., and Kennedy J.L. Glutamate transporter gene SLC1A1 associated with obsessive-compulsive disorder. Arch. Gen. Psychiatry 63 (2006) 769-776
7. Azzam A., and Mathews C.A. Meta-analysis of the association between the catecholamine-O-methyl-transferase gene and obsessive-compulsive disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 123 (2003) 64-69
8. Baca-Garcia E., Vaquero-Lorenzo C., az-Hernandez M., Rodriguez-Salgado B., Dolengevich-Segal H., rrojo-Romero M., Botillo-Martin C., Ceverino A., Piqueras J.F., Perez-Rodriguez M.M., and Saiz-Ruiz J. Association between obsessive-compulsive disorder and a variable number of tandem repeats polymorphism in intron 2 of the serotonin transporter gene. Prog. Neuropsychopharmacol. Biol. Psychiatry 31 (2007) 416-420
9. Bellodi L., Sciuto G., Diaferia G., Ronchi P., and Smeraldi E. Psychiatric disorders in the families of patients with obsessive- compulsive disorder. Psychiatry Res. 42 (1992) 111-120
10. Bengel D., Greenberg B.D., Cora-Locatelli G., Altemus M., Heils A., Li Q., and Murphy D.L. Association of the serotonin transporter promoter regulatory region polymorphism and obsessive-compulsive disorder. Mol. Psychiatry 4 (1999) 463-466
11. Bertolino A., Arciero G., Rubino V., Latorre V., De C.M., Mazzola V., Blasi G., Caforio G., Hariri A., Kolachana B., Nardini M., Weinberger D.R., and Scarabino T. Variation of human amygdala response during threatening stimuli as a function of 5′HTTLPR genotype and personality style. Biol. Psychiatry 57 (2005) 1517-1525
12. Billett E.A., Richter M.A., King N., Heils A., Lesch K.P., and Kennedy J.L. Obsessive compulsive disorder, response to serotonin reuptake inhibitors and the serotonin transporter gene. Mol. Psychiatry 2 (1997) 403-406
13. Billett E.A., Richter M.A., Sam F., Swinson R.P., Dai X.Y., King N., Badri F., Sasaki T., Buchanan J.A., and Kennedy J.L. Investigation of dopamine system genes in obsessive-compulsive disorder. Psychiatr. Genet. 8 (1998) 163-169
14. Black D.W., Noyes Jr. R., Goldstein R.B., and Blum N. A family study of obsessive-compulsive disorder. Arch. Gen. Psychiatry 49 (1992) 362-368
15. Bolton D., Eley T.C., O'connor T.G., Perrin S., Rabe-Hesketh S., Rijsdijk F., and Smith P. Prevalence and genetic and environmental influences on anxiety disorders in 6-year-old twins. Psychol. Med. 36 (2006) 335-344
16. Bolton D., Rijsdijk F., O'connor T.G., Perrin S., and Eley T.C. Obsessive-compulsive disorder, tics and anxiety in 6-year-old twins. Psychol. Med. 37 (2007) 39-48
17. Boomsma D.I., Beem A.L., van den B.M., Dolan C.V., Koopmans J.R., Vink J.M., De Geus E.J., and Slagboom P.E. Netherlands twin family study of anxious depression (NETSAD). Twin Res. 3 (2000) 323-334
18. Boulenger J.P., Jerabek I., Jolicoeur F.B., Lavallee Y.J., Leduc R., and Cadieux A. Elevated plasma levels of neuropeptide Y in patients with panic disorder. Am. J. Psychiatry 153 (1996) 114-116
19. Boulenger J.P., Marangos P.J., Patel J., Uhde T.W., and Post R.M. Central adenosine receptors: possible involvement in the chronic effects of caffeine. Psychopharmacol. Bull. 20 (1984) 431-435
20. Bradwejn J. Neurobiological investigations into the role of cholecystokinin in panic disorder. J. Psychiatry Neurosci. 18 (1993) 178-188
21. Breslau N., Davis G.C., Andreski P., and Peterson E. Traumatic events and posttraumatic stress disorder in an urban population of young adults. Arch. Gen. Psychiatry 48 (1991) 216-222
22. Brown F.W. Heredity in the psychoneuroses. Proc. R. Soc. Med. 35 (1942) 785-790
23. Brown S.M., and Hariri A.R. Neuroimaging studies of serotonin gene polymorphisms: exploring the interplay of genes, brain, and behavior. Cogn. Affect. Behav. Neurosci. 6 (2006) 44-52
24. Brown S.M., Peet E., Manuck S.B., Williamson D.E., Dahl R.E., Ferrell R.E., and Hariri A.R. A regulatory variant of the human tryptophan hydroxylase-2 gene biases amygdala reactivity. Mol. Psychiatry 10 (2005) 884-888 805
25. Camarena B., Aguilar A., Loyzaga C., and Nicolini H. A family-based association study of the 5-HT-1Dbeta receptor gene in obsessive-compulsive disorder. Int. J. Neuropsychopharmacol. 7 (2004) 49-53
26. Camarena B., Cruz C., de Jr. l.F., and Nicolini H. A higher frequency of a low activity-related allele of the MAO-A gene in females with obsessive-compulsive disorder. Psychiatr. Genet. 8 (1998) 255-257
27. Camarena B., Loyzaga C., Aguilar A., Weissbecker K., and Nicolini H. Association study between the dopamine receptor D(4) gene and obsessive-compulsive disorder. Eur. Neuropsychopharmacol 17 (2007) 406-409
28. Camarena B., Rinetti G., Cruz C., Gomez A., de Jr. L.F., and Nicolini H. Additional evidence that genetic variation of MAO-A gene supports a gender subtype in obsessive-compulsive disorder. Am. J. Med. Genet. 105 (2001) 279-282
29. Camarena B., Rinetti G., Cruz C., Hernandez S., de Jr. l.F., and Nicolini H. Association study of the serotonin transporter gene polymorphism in obsessive-compulsive disorder. Int. J. Neuropsychopharmacol. 4 (2001) 269-272
30. Canli T., Congdon E., Gutknecht L., Constable R.T., and Lesch K.P. Amygdala responsiveness is modulated by tryptophan hydroxylase-2 gene variation. J. Neural Transm. 112 (2005) 1479-1485
31. Canli T., Omura K., Haas B.W., Fallgatter A., Constable R.T., and Lesch K.P. Beyond affect: a role for genetic variation of the serotonin transporter in neural activation during a cognitive attention task. Proc. Natl. Acad. Sci. USA 102 (2005) 12224-12229
32. Carey G., and Gottesman I.I. Twin and family studies of anxiety, phobic, and obsessive disorders. In: Klein D.F., and Rabkin Anxiety J. (Eds). New research and changing concepts (1981), Raven Press, New York, NY 117-136
33. Carlson C.S., Eberle M.A., Rieder M.J., Yi Q., Kruglyak L., and Nickerson D.A. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am. J. Hum. Genet. 74 (2004) 106-120
34. Catalano M., Sciuto G., Di Bella D., Novelli E., Nobile M., and Bellodi L. Lack of association between obsessive-compulsive disorder and the dopamine D3 receptor gene: some preliminary considerations. Am. J. Med. Genet. 54 (1994) 253-255
35. Cavallini M.C., Di Bella D., Pasquale L., Henin M., and Bellodi L. 5HT2C CYS23/SER23 polymorphism is not associated with obsessive-compulsive disorder. Psychiatry Res. 77 (1998) 97-104
36. Chabane N., Millet B., Delorme R., Lichtermann D., Mathieu F., Laplanche J.L., Roy I., Mouren M.C., Hankard R., Maier W., Launay J.M., and Leboyer M. Lack of evidence for association between serotonin transporter gene (5-HTTLPR) and obsessive-compulsive disorder by case control and family association study in humans. Neurosci. Lett. 363 (2004) 154-156
37. Chantarujikapong S.I., Scherrer J.F., Xian H., Eisen S.A., Lyons M.J., Goldberg J., Tsuang M., and True W.R. A twin study of generalized anxiety disorder symptoms, panic disorder symptoms and post-traumatic stress disorder in men. Psychiatry Res. 103 (2001) 133-145
38. Charney D.S., Heninger G.R., and Jatlow P.I. Increased anxiogenic effects of caffeine in panic disorders. Arch. Gen. Psychiatry 42 (1985) 233-243
39. Clifford C.A., Murray R.M., and Fulker D.W. Genetic and environmental influences on obsessional traits and symptoms. Psychol. Med. 14 (1984) 791-800
40. Crowe R.R., Goedken R., Samuelson S., Wilson R., Nelson J., and Noyes Jr. R. Genomewide survey of panic disorder. Am. J. Med. Genet. 105 (2001) 105-109
41. Cruz C., Camarena B., King N., Paez F., Sidenberg D., de Jr. l.F., and Nicolini H. Increased prevalence of the seven-repeat variant of the dopamine D4 receptor gene in patients with obsessive-compulsive disorder with tics. Neurosci. Lett. 231 (1997) 1-4
42. Davidson J.R., Tupler L.A., Wilson W.H., and Connor K.M. A family study of chronic post-traumatic stress disorder following rape trauma. J. Psychiatr. Res. 32 (1998) 301-309
43. de Carvalho A.P., Fazzari M., Jankovic J., and Ozelius L.J. Examination of the SGCE gene in Tourette syndrome patients with obsessive-compulsive disorder. Mov. Disord. 19 (2004) 1237-1238
44. Deckert J., Catalano M., Heils A., Di Bella D., Friess F., Politi E., Franke P., Nothen M.M., Maier W., Bellodi L., and Lesch K.P. Functional promoter polymorphism of the human serotonin transporter: lack of association with panic disorder. Psychiatr. Genet. 7 (1997) 45-47
45. Deckert J., Catalano M., Syagailo Y.V., Bosi M., Okladnova O., Di Bella D., Nothen M.M., Maffei P., Franke P., Fritze J., Maier W., Propping P., Beckmann H., Bellodi L., and Lesch K.P. Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum. Mol. Genet. 8 (1999) 621-624
46. Deckert J., Meyer J., Catalano M., Bosi M., Sand P., DiBella D., Ortega G., Stober G., Franke P., Nothen M.M., Fritze J., Maier W., Beckmann H., Propping P., Bellodi L., and Lesch K.P. Novel 5′-regulatory region polymorphisms of the 5-HT2C receptor gene: association study with panic disorder. Int. J. Neuropsychopharmacol. 3 (2000) 321-325
47. Deckert J., Nothen M.M., Franke P., Delmo C., Fritze J., Knapp M., Maier W., Beckmann H., and Propping P. Systematic mutation screening and association study of the A1 and A2a adenosine receptor genes in panic disorder suggest a contribution of the A2a gene to the development of disease. Mol. Psychiatry 3 (1998) 81-85
48. Delorme R., Betancur C., Wagner M., Krebs M.O., Gorwood P., Pearl P., Nygren G., Durand C.M., Buhtz F., Pickering P., Melke J., Ruhrmann S., Anckarsater H., Chabane N., Kipman A., Reck C., Millet B., Roy I., Mouren-Simeoni M.C., Maier W., Rastam M., Gillberg C., Leboyer M., and Bourgeron T. Support for the association between the rare functional variant I425 V of the serotonin transporter gene and susceptibility to obsessive compulsive disorder. Mol. Psychiatry 10 (2005) 1059-1061
49. Delorme R., Krebs M.O., Chabane N., Roy I., Millet B., Mouren-Simeoni M.C., Maier W., Bourgeron T., and Leboyer M. Frequency and transmission of glutamate receptors GRIK2 and GRIK3 polymorphisms in patients with obsessive compulsive disorder. Neuroreport 15 (2004) 699-702
50. Denys D., Van N.F., Deforce D., and Westenberg H. Association between the dopamine D2 receptor TaqI A2 allele and low activity COMT allele with obsessive-compulsive disorder in males. Eur. Neuropsychopharmacol. 16 (2006) 446-450
51. Denys D., Van N.F., Deforce D., and Westenberg H.G. Association between serotonergic candidate genes and specific phenotypes of obsessive compulsive disorder. J. Affect. Disord. 91 (2006) 39-44
52. Di Bella D., Cavallini M.C., and Bellodi L. No association between obsessive-compulsive disorder and the 5-HT(1Dbeta) receptor gene. Am. J. Psychiatry 159 (2002) 1783-1785
53. Di Bella D., Erzegovesi S., Cavallini M.C., and Bellodi L. Obsessive-compulsive disorder, 5-HTTLPR polymorphism and treatment response. Pharmacogenomics J. 2 (2002) 176-181
54. Dickel D.E., Veenstra-VanderWeele J., Bivens N.C., Wu X., Fischer D.J., Van Etten-Lee M., Himle J.A., Leventhal B.L., Cook Jr. E.H., and Hanna G.L. Association studies of serotonin system candidate genes in early-onset obsessive-compulsive disorder. Biol. Psychiatry 61 (2007) 322-329
55. Dickel D.E., Veenstra-VanderWeele J., Cox N.J., Wu X., Fischer D.J., Van Etten-Lee M., Himle J.A., Leventhal B.L., Cook Jr. E.H., and Hanna G.L. Association testing of the positional and functional candidate gene SLC1A1/EAAC1 in early-onset obsessive-compulsive disorder. Arch. Gen. Psychiatry 63 (2006) 778-785
56. Dierker L.C., and Merikangas K.R. Familial psychiatric illness and posttraumatic stress disorder: findings from a family study of substance abuse and anxiety disorders. J. Clin. Psychiatry 62 (2001) 715-720
57. Domschke K., Braun M., Ohrmann P., Suslow T., Kugel H., Bauer J., Hohoff C., Kersting A., Engelien A., Arolt V., Heindel W., and Deckert J. Association of the functional -1019C/G 5-HT1A polymorphism with prefrontal cortex and amygdala activation measured with 3 T fMRI in panic disorder. Int. J. Neuropsychopharmacol. 9 (2006) 349-355
58. Domschke K., Freitag C.M., Kuhlenbaumer G., Schirmacher A., Sand P., Nyhuis P., Jacob C., Fritze J., Franke P., Rietschel M., Garritsen H.S., Fimmers R., Nothen M.M., Lesch K.P., Stogbauer F., and Deckert J. Association of the functional V158M catechol-O-methyl-transferase polymorphism with panic disorder in women. Int. J. Neuropsychopharmacol. 7 (2004) 183-188
59. Domschke K., Kuhlenbaumer G., Schirmacher A., Lorenzi C., Armengol L., DiBella D., Gratacos M., Garritsen H.S., Nothen M.M., Franke P., Sand P., Fritze J., Perez G., Maier W., Sibrowski W., Estivill X., Bellodi L., Ringelstein E.B., Arolt V., Martin-Santos R., Catalano M., Stogbauer F., and Deckert J. Human nuclear transcription factor gene CREM: genomic organization, mutation screening, and association analysis in panic disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 117 (2003) 70-78
60. do Rosario-Campos M.C., Leckman J.F., Curi M., Quatrano S., Katsovitch L., Miguel E.C., and Pauls D.L. A family study of early-onset obsessive-compulsive disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 136 (2005) 92-97
61. Enoch M.A., Greenberg B.D., Murphy D.L., and Goldman D. Sexually dimorphic relationship of a 5-HT2A promoter polymorphism with obsessive-compulsive disorder. Biol. Psychiatry 49 (2001) 385-388
62. Erdal M.E., Tot S., Yazici K., Yazici A., Herken H., Erdem P., Derici E., and Camdeviren H. Lack of association of catechol-O-methyltransferase gene polymorphism in obsessive-compulsive disorder. Depress. Anxiety 18 (2003) 41-45
63. Fanous A.H., and Kendler K.S. Genetic heterogeneity, modifier genes, and quantitative phenotypes in psychiatric illness: searching for a framework. Mol. Psychiatry 10 (2005) 6-13
64. Fehr C., Grintschuk N., Szegedi A., Anghelescu I., Klawe C., Singer P., Hiemke C., and Dahmen N. The HTR1B 861G>C receptor polymorphism among patients suffering from alcoholism, major depression, anxiety disorders and narcolepsy. Psychiatry Res. 97 (2000) 1-10
65. Fehr C., Schleicher A., Szegedi A., Anghelescu I., Klawe C., Hiemke C., and Dahmen N. Serotonergic polymorphisms in patients suffering from alcoholism, anxiety disorders and narcolepsy. Prog. Neuropsychopharmacol. Biol. Psychiatry 25 (2001) 965-982
66. Fehr C., Szegedi A., Anghelescu I., Klawe C., Hiemke C., and Dahmen N. Sex differences in allelic frequencies of the 5-HT2C Cys23Ser polymorphism in psychiatric patients and healthy volunteers: findings from an association study. Psychiatr. Genet. 10 (2000) 59-65
67. Freeman T., Roca V., Guggenheim F., Kimbrell T., and Griffin W.S. Neuropsychiatric associations of apolipoprotein E alleles in subjects with combat-related posttraumatic stress disorder. J. Neuropsychiatry Clin. Neurosci. 17 (2005) 541-543
68. Frisch A., Michaelovsky E., Rockah R., Amir I., Hermesh H., Laor N., Fuchs C., Zohar J., Lerer B., Buniak S.F., Landa S., Poyurovsky M., Shapira B., and Weizman R. Association between obsessive-compulsive disorder and polymorphisms of genes encoding components of the serotonergic and dopaminergic pathways. Eur. Neuropsychopharmacol. 10 (2000) 205-209
69. Furmark T., Tillfors M., Garpenstrand H., Marteinsdottir I., Langstrom B., Oreland L., and Fredrikson M. Serotonin transporter polymorphism related to amygdala excitability and symptom severity in patients with social phobia. Neurosci. Lett. 362 (2004) 189-192
70. Fyer A.J., Hamilton S.P., Durner M., Haghighi F., Heiman G.A., Costa R., Evgrafov O., Adams P., de Leon A.B., Taveras N., Klein D.F., Hodge S.E., Weissman M.M., and Knowles J.A. A third-pass genome scan in panic disorder: evidence for multiple susceptibility loci. Biol. Psychiatry 60 (2006) 388-401
71. Fyer A.J., Lipsitz J.D., Mannuzza S., Aronowitz B., and Chapman T.F. A direct interview family study of obsessive-compulsive disorder. I. Psychol. Med. 35 (2005) 1611-1621
72. Fyer A.J., Mannuzza S., Chapman T.F., Lipsitz J., Martin L.Y., and Klein D.F. Panic disorder and social phobia: effects of comorbidity on familial transmission. Anxiety 2 (1996) 173-178
73. Fyer A.J., Mannuzza S., Chapman T.F., Martin L.Y., and Klein D.F. Specificity in familial aggregation of phobic disorders. Arch. Gen. Psychiatry 52 (1995) 564-573
74. Gelernter J., Bonvicini K., Page G., Woods S.W., Goddard A.W., Kruger S., Pauls D.L., and Goodson S. Linkage genome scan for loci predisposing to panic disorder or agoraphobia. Am. J. Med. Genet. 105 (2001) 548-557
75. Gelernter J., Page G.P., Bonvicini K., Woods S.W., Pauls D.L., and Kruger S. A chromosome 14 risk locus for simple phobia: results from a genomewide linkage scan. Mol. Psychiatry 8 (2003) 71-82
76. Gelernter J., Page G.P., Stein M.B., and Woods S.W. Genome-wide linkage scan for loci predisposing to social phobia: evidence for a chromosome 16 risk locus. Am. J. Psychiatry 161 (2004) 59-66
77. Gelernter J., Southwick S., Goodson S., Morgan A., Nagy L., and Charney D.S. No association between D2 dopamine receptor (DRD2) "A" system alleles, or DRD2 haplotypes, and posttraumatic stress disorder. Biol. Psychiatry 45 (1999) 620-625
78. Gladkevich A., Kauffman H.F., and Korf J. Lymphocytes as a neural probe: potential for studying psychiatric disorders. Prog. Neuropsychopharmacol. Biol. Psychiatry 28 (2004) 559-576
79. Goldstein R.B., Wickramaratne P.J., Horwath E., and Weissman M.M. Familial aggregation and phenomenology of 'early'-onset (at or before age 20 years) panic disorder. Arch. Gen. Psychiatry 54 (1997) 271-278
80. Grados M.A., Riddle M.A., Samuels J.F., Liang K.Y., Hoehn-Saric R., Bienvenu O.J., Walkup J.T., Song D., and Nestadt G. The familial phenotype of obsessive-compulsive disorder in relation to tic disorders: the Hopkins OCD family study. Biol. Psychiatry 50 (2001) 559-565
81. Gunderson K.L., Steemers F.J., Ren H., Ng P., Zhou L., Tsan C., Chang W., Bullis D., Musmacker J., King C., Lebruska L.L., Barker D., Oliphant A., Kuhn K.M., and Shen R. Whole-genome genotyping. Methods Enzymol. 410 (2006) 359-376
82. Hall D., Dhilla A., Charalambous A., Gogos J.A., and Karayiorgou M. Sequence variants of the brain-derived neurotrophic factor (BDNF) gene are strongly associated with obsessive-compulsive disorder. Am. J. Hum. Genet. 73 (2003) 370-376
83. Hamilton S.P., Fyer A.J., Durner M., Heiman G.A., Baisre de L.A., Hodge S.E., Knowles J.A., and Weissman M.M. Further genetic evidence for a panic disorder syndrome mapping to chromosome 13q. Proc. Natl. Acad. Sci. USA 100 (2003) 2550-2555
84. Hamilton S.P., Haghighi F., Heiman G.A., Klein D.F., Hodge S.E., Fyer A.J., Weissman M.M., and Knowles J.A. Investigation of dopamine receptor (DRD4) and dopamine transporter (DAT) polymorphisms for genetic linkage or association to panic disorder. Am. J. Med. Genet. 96 (2000) 324-330
85. Hamilton S.P., Heiman G.A., Haghighi F., Mick S., Klein D.F., Hodge S.E., Weissman M.M., Fyer A.J., and Knowles J.A. Lack of genetic linkage or association between a functional serotonin transporter polymorphism and panic disorder. Psychiatr. Genet. 9 (1999) 1-6
86. Hamilton S.P., Slager S.L., Heiman G.A., Haghighi F., Klein D.F., Hodge S.E., Weissman M.M., Fyer A.J., and Knowles J.A. No genetic linkage or association between a functional promoter polymorphism in the monoamine oxidase-A gene and panic disorder. Mol. Psychiatry 5 (2000) 465-466
87. Hamilton S.P., Slager S.L., De Leon A.B., Heiman G.A., Klein D.F., Hodge S.E., Weissman M.M., Fyer A.J., and Knowles J.A. Evidence for genetic linkage between a polymorphism in the adenosine 2A receptor and panic disorder. Neuropsychopharmacology 29 (2004) 558-565
88. Hamilton S.P., Slager S.L., Heiman G.A., Deng Z., Haghighi F., Klein D.F., Hodge S.E., Weissman M.M., Fyer A.J., and Knowles J.A. Evidence for a susceptibility locus for panic disorder near the catechol-O-methyltransferase gene on chromosome 22. Biol. Psychiatry 51 (2002) 591-601
89. Hamilton S.P., Slager S.L., Helleby L., Heiman G.A., Klein D.F., Hodge S.E., Weissman M.M., Fyer A.J., and Knowles J.A. No association or linkage between polymorphisms in the genes encoding cholecystokinin and the cholecystokinin B receptor and panic disorder. Mol. Psychiatry 6 (2001) 59-65
90. Han L., Nielsen D.A., Rosenthal N.E., Jefferson K., Kaye W., Murphy D., Altemus M., Humphries J., Cassano G., Rotondo A., Virkkunen M., Linnoila M., and Goldman D. No coding variant of the tryptophan hydroxylase gene detected in seasonal affective disorder, obsessive-compulsive disorder, anorexia nervosa, and alcoholism. Biol. Psychiatry 45 (1999) 615-619
91. Hanna G.L., Himle J.A., Curtis G.C., and Gillespie B.W. A family study of obsessive-compulsive disorder with pediatric probands. Am. J. Med. Genet. B Neuropsychiatr. Genet. 134 (2005) 13-19
92. Hanna G.L., Veenstra-VanderWeele J., Cox N.J., Boehnke M., Himle J.A., Curtis G.C., Leventhal B.L., and Cook Jr. E.H. Genome-wide linkage analysis of families with obsessive-compulsive disorder ascertained through pediatric probands. Am. J. Med. Genet. 114 (2002) 541-552
93. Hariri A.R., Drabant E.M., Munoz K.E., Kolachana B.S., Mattay V.S., Egan M.F., and Weinberger D.R. A susceptibility gene for affective disorders and the response of the human amygdala. Arch. Gen. Psychiatry 62 (2005) 146-152
94. Hariri A.R., Mattay V.S., Tessitore A., Kolachana B., Fera F., Goldman D., Egan M.F., and Weinberger D.R. Serotonin transporter genetic variation and the response of the human amygdala. Science 297 (2002) 400-403
95. Hariri A.R., and Weinberger D.R. Functional neuroimaging of genetic variation in serotonergic neurotransmission. Genes Brain Behav. 2 (2003) 341-349
96. Hasler G., Drevets W.C., Manji H.K., and Charney D.S. Discovering endophenotypes for major depression. Neuropsychopharmacology 29 (2004) 1765-1781
97. Hasler G., Kazuba D., and Murphy D.L. Factor analysis of obsessive-compulsive disorder YBOCS-SC symptoms and association with 5-HTTLPR SERT polymorphism. Am. J. Med. Genet. B Neuropsychiatr. Genet. 141 (2006) 403-408
98. Hattori E., Yamada K., Toyota T., Yoshitsugu K., Toru M., Shibuya H., and Yoshikawa T. Association studies of the CT repeat polymorphism in the 5′ upstream region of the cholecystokinin B receptor gene with panic disorder and schizophrenia in Japanese subjects. Am. J. Med. Genet. 105 (2001) 779-782
99. Heinz A., Braus D.F., Smolka M.N., Wrase J., Puls I., Hermann D., Klein S., Grusser S.M., Flor H., Schumann G., Mann K., and Buchel C. Amygdala-prefrontal coupling depends on a genetic variation of the serotonin transporter. Nat. Neurosci. 8 (2005) 20-21
100. Heinz A., Smolka M.N., Braus D.F., Wrase J., Beck A., Flor H., Mann K., Schumann G., Buchel C., Hariri A.R., and Weinberger D.R. Serotonin transporter genotype (5-HTTLPR): effects of neutral and undefined conditions on amygdala activation. Biol. Psychiatry 61 (2007) 1011-1014
101. Hemmings S.M., Kinnear C.J., Lochner C., Niehaus D.J., Knowles J.A., Moolman-Smook J.C., Corfield V.A., and Stein D.J. Early- versus late-onset obsessive-compulsive disorder: investigating genetic and clinical correlates. Psychiatry Res. 128 (2004) 175-182
102. Hemmings S.M., Kinnear C.J., Niehaus D.J., Moolman-Smook J.C., Lochner C., Knowles J.A., Corfield V.A., and Stein D.J. Investigating the role of dopaminergic and serotonergic candidate genes in obsessive-compulsive disorder. Eur. Neuropsychopharmacol. 13 (2003) 93-98
103. Hemmings S.M., and Stein D.J. The current status of association studies in obsessive-compulsive disorder. Psychiatr. Clin. North Am. 29 (2006) 411-444
104. Hettema J.M., An S.S., Neale M.C., Bukszar J., van den Oord E.J., Kendler K.S., and Chen X. Association between glutamic acid decarboxylase genes and anxiety disorders, major depression, and neuroticism. Mol. Psychiatry 11 (2006) 752-762
105. Hettema J.M., Neale M.C., and Kendler K.S. A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am. J. Psychiatry 158 (2001) 1568-1578
106. Hettema J.M., Neale M.C., Myers J.M., Prescott C.A., and Kendler K.S. A population-based twin study of the relationship between neuroticism and internalizing disorders. Am. J. Psychiatry 163 (2006) 857-864
107. Hettema J.M., Prescott C.A., and Kendler K.S. A population-based twin study of generalized anxiety disorder in men and women. J. Nerv. Ment. Dis. 189 (2001) 413-420
108. Hettema J.M., Prescott C.A., Myers J.M., Neale M.C., and Kendler K.S. The structure of genetic and environmental risk factors for anxiety disorders in men and women. Arch. Gen. Psychiatry 62 (2005) 182-189
109. Hirschhorn J.N., and Daly M.J. Genome-wide association studies for common diseases and complex traits. Nat. Rev. Genet. 6 (2005) 95-108
110. Ho H.P., Westberg L., Annerbrink K., Olsson M., Melke J., Nilsson S., Baghaei F., Rosmond R., Holm G., Bjorntorp P., Andersch S., Allgulander C., and Eriksson E. Association between a functional polymorphism in the progesterone receptor gene and panic disorder in women. Psychoneuroendocrinology 29 (2004) 1138-1141
111. Hosing V.G., Schirmacher A., Kuhlenbaumer G., Freitag C., Sand P., Schlesiger C., Jacob C., Fritze J., Franke P., Rietschel M., Garritsen H., Nothen M.M., Fimmers R., Stogbauer F., and Deckert J. Cholecystokinin- and cholecystokinin-B-receptor gene polymorphisms in panic disorder. J. Neural Transm. Suppl. 68 (2004) 147-156
112. Huang Y.Y., Battistuzzi C., Oquendo M.A., Harkavy-Friedman J., Greenhill L., Zalsman G., Brodsky B., Arango V., Brent D.A., and Mann J.J. Human 5-HT1A receptor C(-1019)G polymorphism and psychopathology. Int. J. Neuropsychopharmacol. 7 (2004) 441-451
113. Hudziak J.J., van Beijsterveldt C.E., Althoff R.R., Stanger C., Rettew D.C., Nelson E.C., Todd R.D., Bartels M., and Boomsma D.I. Genetic and environmental contributions to the Child Behavior Checklist Obsessive-Compulsive Scale: a cross-cultural twin study. Arch. Gen. Psychiatry 61 (2004) 608-616
114. Inada Y., Yoneda H., Koh J., Sakai J., Himei A., Kinoshita Y., Akabame K., Hiraoka Y., and Sakai T. Positive association between panic disorder and polymorphism of the serotonin 2A receptor gene. Psychiatry Res. 118 (2003) 25-31
115. Insel T.R., Hoover C., and Murphy D.L. Parents of patients with obsessive-compulsive disorder. Psychol. Med. 13 (1983) 807-811
116. Ishiguro H., Arinami T., Yamada K., Otsuka Y., Toru M., and Shibuya H. An association study between a transcriptional polymorphism in the serotonin transporter gene and panic disorder in a Japanese population. Psychiatry Clin. Neurosci. 51 (1997) 333-335
117. Jonnal A.H., Gardner C.O., Prescott C.A., and Kendler K.S. Obsessive and compulsive symptoms in a general population sample of female twins. Am. J. Med. Genet. 96 (2000) 791-796
118. Kaabi B., Gelernter J., Woods S.W., Goddard A., Page G.P., and Elston R.C. Genome scan for loci predisposing to anxiety disorders using a novel multivariate approach: strong evidence for a chromosome 4 risk locus. Am. J. Hum. Genet. 78 (2006) 543-553
119. Karayiorgou M., Sobin C., Blundell M.L., Galke B.L., Malinova L., Goldberg P., Ott J., and Gogos J.A. Family-based association studies support a sexually dimorphic effect of COMT and MAOA on genetic susceptibility to obsessive-compulsive disorder. Biol. Psychiatry 45 (1999) 1178-1189
120. Kendler K.S. Major depression and generalised anxiety disorder, (partly) different environments - revisited. Br. J. Psychiatry 168 (1996) 68-75
121. Kendler K.S., Gardner C.O., and Prescott C.A. Panic syndromes in a population-based sample of male and female twins. Psychol. Med. 31 (2001) 989-1000
122. Kendler K.S., Jacobson K.C., Myers J., and Prescott C.A. Sex differences in genetic and environmental risk factors for irrational fears and phobias. Psychol. Med. 32 (2002) 209-217
123. Kendler K.S., Karkowski L.M., and Prescott C.A. Fears and phobias: reliability and heritability. Psychol. Med. 29 (1999) 539-553
124. Kendler K.S., Myers J., Prescott C.A., and Neale M.C. The genetic epidemiology of irrational fears and phobias in men. Arch. Gen. Psychiatry 58 (2001) 257-265
125. Kendler K.S., Neale M.C., Kessler R.C., Heath A.C., and Eaves L.J. Generalized anxiety disorder in women. A population-based twin study. Arch. Gen. Psychiatry 49 (1992) 267-272
126. Kendler K.S., Neale M.C., Kessler R.C., Heath A.C., and Eaves L.J. Major depression and generalized anxiety disorder. Same genes, (partly) different environments?. Arch. Gen. Psychiatry 49 (1992) 716-722
127. Kendler K.S., Neale M.C., Kessler R.C., Heath A.C., and Eaves L.J. The genetic epidemiology of phobias in women. The interrelationship of agoraphobia, social phobia, situational phobia, and simple phobia. Arch. Gen. Psychiatry 49 (1992) 273-281
128. Kendler K.S., Neale M.C., Kessler R.C., Heath A.C., and Eaves L.J. Major depression and phobias: the genetic and environmental sources of comorbidity. Psychol. Med. 23 (1993) 361-371
129. Kendler K.S., Neale M.C., Kessler R.C., Heath A.C., and Eaves L.J. Panic disorder in women: a population-based twin study. Psychol. Med. 23 (1993) 397-406
130. Kendler K.S., Prescott C.A., Myers J., and Neale M.C. The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women. Arch. Gen. Psychiatry 60 (2003) 929-937
131. Kennedy J.L., Bradwejn J., Koszycki D., King N., Crowe R., Vincent J., and Fourie O. Investigation of cholecystokinin system genes in panic disorder. Mol. Psychiatry 4 (1999) 284-285
132. Kennedy J.L., Neves-Pereira M., King N., Lizak M.V., Basile V.S., Chartier M.J., and Stein M.B. Dopamine system genes not linked to social phobia. Psychiatr. Genet. 11 (2001) 213-217
133. Kim W., Choi Y.H., Yoon K.S., Cho D.Y., Pae C.U., and Woo J.M. Tryptophan hydroxylase and serotonin transporter gene polymorphism does not affect the diagnosis, clinical features and treatment outcome of panic disorder in the Korean population. Prog. Neuropsychopharmacol. Biol. Psychiatry 30 (2006) 1413-1418
134. Kinnear C., Niehaus D.J., Seedat S., Moolman-Smook J.C., Corfield V.A., Malherbe G., Potgieter A., Lombard C., and Stein D.J. Obsessive-compulsive disorder and a novel polymorphism adjacent to the oestrogen response element (ERE 6) upstream from the COMT gene. Psychiatr. Genet. 11 (2001) 85-87
135. Kinnear C.J., Niehaus D.J., Moolman-Smook J.C., du Toit P.L., van K.J., Weyers J.B., Potgieter A., Marais V., Emsley R.A., Knowles J.A., Corfield V.A., Brink P.A., and Stein D.J. Obsessive-compulsive disorder and the promoter region polymorphism (5-HTTLPR) in the serotonin transporter gene (SLC6A4): a negative association study in the Afrikaner population. Int. J. Neuropsychopharmacol. 3 (2000) 327-331
136. Kirk K.M., Birley A.J., Statham D.J., Haddon B., Lake R.I., Andrews J.G., and Martin N.G. Anxiety and depression in twin and sib pairs extremely discordant and concordant for neuroticism: prodromus to a linkage study. Twin Res. 3 (2000) 299-309
137. Kirov G., Murphy K.C., Arranz M.J., Jones I., McCandles F., Kunugi H., Murray R.M., McGuffin P., Collier D.A., Owen M.J., and Craddock N. Low activity allele of catechol-O-methyltransferase gene associated with rapid cycling bipolar disorder. Mol. Psychiatry 3 (1998) 342-345
138. Knowles J.A., Fyer A.J., Vieland V.J., Weissman M.M., Hodge S.E., Heiman G.A., Haghighi F., de Jesus G.M., Rassnick H., Preud'homme-Rivelli X., Austin T., Cunjak J., Mick S., Fine L.D., Woodley K.A., Das K., Maier W., Adams P.B., Freimer N.B., Klein D.F., and Gilliam T.C. Results of a genome-wide genetic screen for panic disorder. Am. J. Med. Genet. 81 (1998) 139-147
139. Kringlen E. Obsessional neurotics: a long-term follow-up. Br. J. Psychiatry 111 (1965) 700-722
140. Lam P., Cheng C.Y., Hong C.J., and Tsai S.J. Association study of a brain-derived neurotrophic factor (Val66Met) genetic polymorphism and panic disorder. Neuropsychobiology 49 (2004) 178-181
141. Lam P., Hong C.J., and Tsai S.J. Association study of A2a adenosine receptor genetic polymorphism in panic disorder. Neurosci. Lett. 378 (2005) 98-101
142. Lee H.J., Lee M.S., Kang R.H., Kim H., Kim S.D., Kee B.S., Kim Y.H., Kim Y.K., Kim J.B., Yeon B.K., Oh K.S., Oh B.H., Yoon J.S., Lee C., Jung H.Y., Chee I.S., and Paik I.H. Influence of the serotonin transporter promoter gene polymorphism on susceptibility to posttraumatic stress disorder. Depress. Anxiety 21 (2005) 135-139
143. Lee Y.J., Hohoff C., Domschke K., Sand P., Kuhlenbaumer G., Schirmacher A., Freitag C.M., Meyer J., Stober G., Franke P., Nothen M.M., Fritze J., Fimmers R., Garritsen H.S., Stogbauer F., and Deckert J. Norepinephrine transporter (NET) promoter and 5′-UTR polymorphisms: association analysis in panic disorder. Neurosci. Lett. 377 (2005) 40-43
144. Lemonde S., Turecki G., Bakish D., Du L., Hrdina P.D., Bown C.D., Sequeira A., Kushwaha N., Morris S.J., Basak A., Ou X.M., and Albert P.R. Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. J. Neurosci. 23 (2003) 8788-8799
145. Lenane M.C., Swedo S.E., Leonard H., Pauls D.L., Sceery W., and Rapoport J.L. Psychiatric disorders in first degree relatives of children and adolescents with obsessive compulsive disorder. J. Am. Acad. Child Adolesc. Psychiatry 29 (1990) 407-412
146. Lerer B., Macciardi F., Segman R.H., Adolfsson R., Blackwood D., Blairy S., Del F.J., Dikeos D.G., Kaneva R., Lilli R., Massat I., Milanova V., Muir W., Noethen M., Oruc L., Petrova T., Papadimitriou G.N., Rietschel M., Serretti A., Souery D., Van G.S., Van B.C., and Mendlewicz J. Variability of 5-HT2C receptor cys23ser polymorphism among European populations and vulnerability to affective disorder. Mol. Psychiatry 6 (2001) 579-585
147. Lesch K.P., Bengel D., Heils A., Sabol S.Z., Greenberg B.D., Petri S., Benjamin J., Muller C.R., Hamer D.H., and Murphy D.L. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274 (1996) 1527-1531
148. Lesch K.P., and Gutknecht L. Focus on The 5-HT1A receptor: emerging role of a gene regulatory variant in psychopathology and pharmacogenetics. Int. J. Neuropsychopharmacol. 7 (2004) 381-385
149. Leygraf A., Hohoff C., Freitag C., Willis-Owen S.A., Krakowitzky P., Fritze J., Franke P., Bandelow B., Fimmers R., Flint J., and Deckert J. Rgs 2 gene polymorphisms as modulators of anxiety in humans?. J. Neural Transm. 113 (2006) 1921-1925
150. Lindberg C., Koefoed P., Hansen E.S., Bolwig T.G., Rehfeld J.F., Mellerup E., Jorgensen O.S., Kessing L.V., Werge T., Haugbol S., Wang A.G., and Woldbye D.P. No association between the -399 C > T polymorphism of the neuropeptide Y gene and schizophrenia, unipolar depression or panic disorder in a Danish population. Acta Psychiatr. Scand. 113 (2006) 54-58
151. Lipsitz J.D., Mannuzza S., Chapman T.F., Foa E.B., Franklin M.E., Goodwin R.D., and Fyer A.J. A direct interview family study of obsessive-compulsive disorder. II. Contribution of proband informant information. Psychol. Med. 35 (2005) 1623-1631
152. Lo W.H. A follow-up study of obsessional neurotics in Hong Kong Chinese. Br. J. Psychiatry 113 (1967) 823-832
153. Logue M.W., Vieland V.J., Goedken R.J., and Crowe R.R. Bayesian analysis of a previously published genome screen for panic disorder reveals new and compelling evidence for linkage to chromosome 7. Am. J. Med. Genet. B Neuropsychiatr. Genet. 121 (2003) 95-99
154. Lohmueller K.E., Pearce C.L., Pike M., Lander E.S., and Hirschhorn J.N. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat. Genet. 33 (2003) 177-182
155. Maier W., Lichtermann D., Minges J., Oehrlein A., and Franke P. A controlled family study in panic disorder. J. Psychiatr. Res. 27 (1993) 79-87
156. Mannuzza S., Schneier F.R., Chapman T.F., Liebowitz M.R., Klein D.F., and Fyer A.J. Generalized social phobia: reliability and validity. Arch. Gen. Psychiatry 52 (1995) 230-237
157. Maron E., Lang A., Tasa G., Liivlaid L., Toru I., Must A., Vasar V., and Shlik J. Associations between serotonin-related gene polymorphisms and panic disorder. Int. J. Neuropsychopharmacol. 8 (2005) 261-266
158. Maron E., Nikopensius T., Koks S., Altmae S., Heinaste E., Vabrit K., Tammekivi V., Hallast P., Koido K., Kurg A., Metspalu A., Vasar E., Vasar V., and Shlik J. Association study of 90 candidate gene polymorphisms in panic disorder. Psychiatr. Genet. 15 (2005) 17-24
159. Maron E., Tasa G., Toru I., Lang A., Vasar V., and Shlik J. Association between serotonin-related genetic polymorphisms and CCK-4-induced panic attacks with or without 5-hydroxytryptophan pretreatment in healthy volunteers. World J. Biol. Psychiatry 5 (2004) 149-154
160. Maron E., Toru I., Must A., Tasa G., Toover E., Vasar V., Lang A., and Shlik J. Association study of tryptophan hydroxylase 2 gene polymorphisms in panic disorder. Neurosci. Lett. 411 (2007) 180-184
161. Martinez-Barrondo S., Saiz P.A., Morales B., Garcia-Portilla M.P., Coto E., Alvarez V., Bascaran M.T., Bousono M., and Bobes J. Negative evidences in association between apolipoprotein E polymorphism and panic disorder. Eur. Psychiatry 21 (2006) 59-61
162. Massat I., Souery D., Del-Favero J., Nothen M., Blackwood D., Muir W., Kaneva R., Serretti A., Lorenzi C., Rietschel M., Milanova V., Papadimitriou G.N., Dikeos D., Van B.C., and Mendlewicz J. Association between COMT (Val158Met) functional polymorphism and early onset in patients with major depressive disorder in a European multicenter genetic association study. Mol. Psychiatry 10 (2005) 598-605
163. McDougle C.J., Epperson C.N., Price L.H., and Gelernter J. Evidence for linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and obsessive compulsive disorder. Mol. Psychiatry 3 (1998) 270-273
164. McGrath M., Kawachi I., Ascherio A., Colditz G.A., Hunter D.J., and De V.I. Association between catechol-O-methyltransferase and phobic anxiety. Am. J. Psychiatry 161 (2004) 1703-1705
165. McKeon P., and Murray R. Familial aspects of obsessive-compulsive neurosis. Br. J. Psychiatry 151 (1987) 528-534
166. Meira-Lima I., Shavitt R.G., Miguita K., Ikenaga E., Miguel E.C., and Vallada H. Association analysis of the catechol-o-methyltransferase (COMT), serotonin transporter (5-HTT) and serotonin 2A receptor (5HT2A) gene polymorphisms with obsessive-compulsive disorder. Genes Brain Behav. 3 (2004) 75-79
167. Mendlewicz J., Papadimitriou G.N., and Wilmotte J. Family study of panic disorder: comparison with generalized anxiety disorder, major depression and normal subjects. Psychiatr. Genet. 3 (1993) 73-78
168. Miguita K., Cordeiro Q., Shavitt R.G., Miguel E.C., and Vallada H. Association study between the 1287 A/G exonic polymorphism of the norepinephrine transporter (NET) gene and obsessive-compulsive disorder in a Brazilian sample. Rev. Bras. Psiquiatr. 28 (2006) 158-159
169. Millet B., Chabane N., Delorme R., Leboyer M., Leroy S., Poirier M.F., Bourdel M.C., Mouren-Simeoni M.C., Rouillon F., Loo H., and Krebs M.O. Association between the dopamine receptor D4 (DRD4) gene and obsessive-compulsive disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 116 (2003) 55-59
170. Miyasaka K., Yoshida Y., Matsushita S., Higuchi S., Shirakawa O., Shimokata H., and Funakoshi A. Association of cholecystokinin-A receptor gene polymorphisms and panic disorder in Japanese. Am. J. Med. Genet. B Neuropsychiatr. Genet. 127 (2004) 78-80
171. Mossner R., Freitag C.M., Gutknecht L., Reif A., Tauber R., Franke P., Fritze J., Wagner G., Peikert G., Wenda B., Sand P., Rietschel M., Garritsen H., Jacob C., Lesch K.P., and Deckert J. The novel brain-specific tryptophan hydroxylase-2 gene in panic disorder. J. Psychopharmacol. 20 (2006) 547-552
172. Mossner R., Walitza S., Geller F., Scherag A., Gutknecht L., Jacob C., Bogusch L., Remschmidt H., Simons M., Herpertz-Dahlmann B., Fleischhaker C., Schulz E., Warnke A., Hinney A., Wewetzer C., and Lesch K.P. Transmission disequilibrium of polymorphic variants in the tryptophan hydroxylase-2 gene in children and adolescents with obsessive-compulsive disorder. Int. J. Neuropsychopharmacol. 9 (2006) 437-442
173. Mossner R., Walitza S., Lesch K.P., Geller F., Barth N., Remschmidt H., Hahn F., Herpertz-Dahlmann B., Fleischhaker C., Schulz E., Warnke A., Hinney A., and Wewetzer C. Brain-derived neurotrophic factor V66M polymorphism in childhood-onset obsessive-compulsive disorder. Int. J. Neuropsychopharmacol. 8 (2005) 133-136
174. Mundo E., Richter M.A., Sam F., Macciardi F., and Kennedy J.L. Is the 5-HT(1Dbeta) receptor gene implicated in the pathogenesis of obsessive-compulsive disorder?. Am. J. Psychiatry 157 (2000) 1160-1161
175. Mundo E., Richter M.A., Zai G., Sam F., McBride J., Macciardi F., and Kennedy J.L. 5HT1Dbeta receptor gene implicated in the pathogenesis of obsessive-compulsive disorder: further evidence from a family-based association study. Mol. Psychiatry 7 (2002) 805-809
176. Murphy Jr. G.M. Application of microarray technology in psychotropic drug trials. J. Psychopharmacol. 20 (2006) 72-78
177. Nakamura K., Yamada K., Iwayama Y., Toyota T., Furukawa A., Takimoto T., Terayama H., Iwahashi K., Takei N., Minabe Y., Sekine Y., Suzuki K., Iwata Y., Pillai A., Nakamoto Y., Ikeda K., Yoshii M., Fukunishi I., Yoshikawa T., and Mori N. Evidence that variation in the peripheral benzodiazepine receptor (PBR) gene influences susceptibility to panic disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 141 (2006) 222-226
178. Nakamura M., Ueno S., Sano A., and Tanabe H. Polymorphisms of the human homologue of the Drosophila white gene areassociated with mood and panic disorders. Mol. Psychiatry 4 (1999) 155-162
179. Neale M.C., and Cardon L.R. Methodology for Genetic Studies of Twins and Families (1992), Kluwer Academic Publishers B.V. Dordrecht, Dordrecht, The Netherlands
180. Neale M.C., Eaves L.J., and Kendler K.S. The power of the classical twin study to resolve variation in threshold traits. Behav. Genet. 24 (1994) 239-258
181. Neale M.C., Walters E.E., Eaves L.J., Kessler R.C., Heath A.C., and Kendler K.S. Genetics of blood-injury fears and phobias: a population-based twin study. Am. J. Med. Genet. 54 (1994) 326-334
182. Nelson E.C., Grant J.D., Bucholz K.K., Glowinski A., Madden P.A.F., Reich W., and Heath A.C. Social phobia in a population-based female adolescent twin sample: co-morbidity and associated suicide-related symptoms. Psychol. Med. 30 (2000) 797-804
183. Nestadt G., Samuels J., Riddle M., Bienvenu III O.J., Liang K.Y., LaBuda M., Walkup J., Grados M., and Hoehn-Saric R. A family study of obsessive-compulsive disorder. Arch. Gen. Psychiatry 57 (2000) 358-363
184. Nestadt G., Samuels J., Riddle M.A., Liang K.Y., Bienvenu O.J., Hoehn-Saric R., Grados M., and Cullen B. The relationship between obsessive-compulsive disorder and anxiety and affective disorders: results from the Johns Hopkins OCD Family Study. Psychol. Med. 31 (2001) 481-487
185. Newman S.C., and Bland R.C. A population-based family study of DSM-III generalized anxiety disorder. Psychol. Med. 36 (2006) 1275-1281
186. Nicolini H., Urraca N., Camarena B., Gomez A., Martinez H., Rinetti G., Campillo C., Castelli P., Apiquian R., Fresan A., Garcia-Anaya M., and Cruz C. Lack of association of apolipoprotein E polymorphism in obsessive-compulsive disorder. CNS. Spectr. 6 (2001) 978-979 992
187. Nicolini H., Weissbecker K., Mejia J.M., and Sanchez D.C. Family study of obsessive-compulsive disorder in a Mexican population. Arch. Med. Res. 24 (1993) 193-198
188. Noyes Jr. R., Clarkson C., Crowe R.R., Yates W.R., and McChesney C.M. A family study of generalized anxiety disorder. Am. J. Psychiatry 144 (1987) 1019-1024
189. Noyes Jr. R., Crowe R.R., Harris E.L., Hamra B.J., McChesney C.M., and Chaudhry D.R. Relationship between panic disorder and agoraphobia. A family study. Arch. Gen. Psychiatry 43 (1986) 227-232
190. Ohara K., Nagai M., Suzuki Y., Ochiai M., and Ohara K. No association between anxiety disorders and catechol-O-methyltransferase polymorphism. Psychiatry Res. 80 (1998) 145-148
191. Olsson M., Annerbrink K., Westberg L., Melke J., Baghaei F., Rosmond R., Holm G., Andersch S., Allgulander C., and Eriksson E. Angiotensin-related genes in patients with panic disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 127 (2004) 81-84
192. Ozaki N., Goldman D., Kaye W.H., Plotnicov K., Greenberg B.D., Lappalainen J., Rudnick G., and Murphy D.L. Serotonin transporter missense mutation associated with a complex neuropsychiatric phenotype. Mol. Psychiatry 8 (2003) 933-936
193. Page A.C., and Martin N.G. Testing a genetic structure of blood-injury-injection fears. Am. J. Med. Genet. 81 (1998) 377-384
194. Pauls D.L., Alsobrook J.P., Goodman W., Rasmussen S., and Leckman J.F. A family study of obsessive-compulsive disorder. Am. J. Psychiatry 152 (1995) 76-84
195. Perna G., Caldirola D., Arancio C., and Bellodi L. Panic attacks: a twin study. Psychiatry Res. 66 (1997) 69-71
196. 2 reactivity and serotonin transporter gene regulatory region polymorphism in panic disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 129 (2004) 41-43
197. Perna G., Favaron E., Di Bella D., Bussi R., and Bellodi L. Antipanic efficacy of paroxetine and polymorphism within the promoter of the serotonin transporter gene. Neuropsychopharmacology 30 (2005) 2230-2235
198. Philibert R.A., Crowe R., Ryu G.Y., Yoon J.G., Secrest D., Sandhu H., and Madan A. Transcriptional profiling of lymphoblast lines from subjects with panic disorder. Am. J Med. Genet. B Neuropsychiatr. Genet 144 (2007) 674-682
199. Philibert R.A., Nelson J.J., Bedell B., Goedken R., Sandhu H.K., Noyes Jr. R., and Crowe R.R. Role of elastin polymorphisms in panic disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 117 (2003) 7-10
200. Pickar D., and Rubinow K. Pharmacogenomics of psychiatric disorders. Trends Pharmacol. Sci. 22 (2001) 75-83
201. Politi P., Minoretti P., Falcone C., Martinelli V., and Emanuele E. Association analysis of the functional Ala111Glu polymorphism of the glyoxalase I gene in panic disorder. Neurosci. Lett. 396 (2006) 163-166
202. Pritchard J.K., and Cox N.J. The allelic architecture of human disease genes: common disease - common variant...or not?. Hum. Mol. Genet. 11 (2002) 2417-2423
203. Rasmussen S.A., and Tsuang M.T. Clinical characteristics and family history in DSM-III obsessive-compulsive disorder. Am. J. Psychiatry 143 (1986) 317-322
204. Riddle M.A., Scahill L., King R., Hardin M.T., Towbin K.E., Ort S.I., Leckman J.F., and Cohen D.J. Obsessive compulsive disorder in children and adolescents: phenomenology and family history. J. Am. Acad. Child Adolesc. Psychiatry 29 (1990) 766-772
205. Rose R.J., Miller J.Z., Pogue-Geile M.F., and Cardwell G.F. Twin-family studies of common fears and phobias. In: Gedda L., Parisi P., and Nance W.E. (Eds). Twin Research 3: Intelligence, Personality, and Development (1981), Alan R. Liss, Inc., New York, NY 169-174
206. Rosenberg C.M. Familial aspects of obsessional neurosis. Br. J. Psychiatry 113 (1967) 405-413
207. Rothe C., Gutknecht L., Freitag C., Tauber R., Mossner R., Franke P., Fritze J., Wagner G., Peikert G., Wenda B., Sand P., Jacob C., Rietschel M., Nothen M.M., Garritsen H., Fimmers R., Deckert J., and Lesch K.P. Association of a functional 1019C>G 5-HT1A receptor gene polymorphism with panic disorder with agoraphobia. Int. J. Neuropsychopharmacol. 7 (2004) 189-192
208. Rothe C., Koszycki D., Bradwejn J., King N., De L.V., Shaikh S., Franke P., Garritsen H., Fritze J., Deckert J., and Kennedy J.L. Association study of serotonin-2A receptor gene polymorphism and panic disorder in patients from Canada and Germany. Neurosci. Lett. 363 (2004) 276-279
209. Rothe C., Koszycki D., Bradwejn J., King N., Deluca V., Tharmalingam S., Macciardi F., Deckert J., and Kennedy J.L. Association of the Val158Met catechol O-methyltransferase genetic polymorphism with panic disorder. Neuropsychopharmacology 31 (2006) 2237-2242
210. Roy M.A., Neale M.C., Pedersen N.L., Mathe A.A., and Kendler K.S. A twin study of generalized anxiety disorder and major depression. Psychol. Med. 25 (1995) 1037-1049
211. Rudin E. Ein beitrag zur frage der zwangskrankheit insbesondere ihrer hereditaren beziehungen. Arch. Psychiatr. Nervenkrankheit 191 (1953) 14-54
212. Samochowiec J., Hajduk A., Samochowiec A., Horodnicki J., Stepien G., Grzywacz A., and Kucharska-Mazur J. Association studies of MAO-A, COMT, and 5-HTT genes polymorphisms in patients with anxiety disorders of the phobic spectrum. Psychiatry Res. 128 (2004) 21-26
213. Sand P.G., Godau C., Riederer P., Peters C., Franke P., Nothen M.M., Stober G., Fritze J., Maier W., Propping P., Lesch K.P., Riess O., Sander T., Beckmann H., and Deckert J. Exonic variants of the GABA(B) receptor gene and panic disorder. Psychiatr. Genet. 10 (2000) 191-194
214. Sand P.G., Schlurmann K., Luckhaus C., Gotz M., Stober G., Lesch K.P., Riederer P., Franke P., Maier W., Nothen M.M., Propping P., Fritze J., and Deckert J. Estrogen receptor 1 gene (ESR1) variants in panic disorder. Am. J. Med. Genet. 114 (2002) 426-428
215. Scherrer J.F., True W.R., Xian H., Lyons M.J., Eisen S.A., Goldberg J., Lin N., and Tsuang M.T. Evidence for genetic influences common and specific to symptoms of generalized anxiety and panic. J. Affect. Disord. 57 (2000) 25-35
216. Schindler K.M., Richter M.A., Kennedy J.L., Pato M.T., and Pato C.N. Association between homozygosity at the COMT gene locus and obsessive compulsive disorder. Am. J. Med. Genet. 96 (2000) 721-724
217. Schmidt N.B., Storey J., Greenberg B.D., Santiago H.T., Li Q., and Murphy D.L. Evaluating gene × psychological risk factor effects in the pathogenesis of anxiety: a new model approach. J. Abnorm. Psychol. 109 (2000) 308-320
218. Sciuto G., Pasquale L., and Bellodi L. Obsessive compulsive disorder and mood disorders: a family study. Am. J. Med. Genet. 60 (1995) 475-479
219. Segman R.H., Cooper-Kazaz R., Macciardi F., Goltser T., Halfon Y., Dobroborski T., and Shalev A.Y. Association between the dopamine transporter gene and posttraumatic stress disorder. Mol. Psychiatry 7 (2002) 903-907
220. Segman R.H., Shefi N., Goltser-Dubner T., Friedman N., Kaminski N., and Shalev A.Y. Peripheral blood mononuclear cell gene expression profiles identify emergent post-traumatic stress disorder among trauma survivors. Mol. Psychiatry 10 (2005) 500-513 425
221. Serretti A., Benedetti F., Zanardi R., and Smeraldi E. The influence of serotonin transporter promoter polymorphism (SERTPR) and other polymorphisms of the serotonin pathway on the efficacy of antidepressant treatments. Prog. Neuropsychopharmacol. Biol. Psychiatry 29 (2005) 1074-1084
222. Shifman S., Bronstein M., Sternfeld M., Pisante-Shalom A., Lev-Lehman E., Weizman A., Reznik I., Spivak B., Grisaru N., Karp L., Schiffer R., Kotler M., Strous R.D., Swartz-Vanetik M., Knobler H.Y., Shinar E., Beckmann J.S., Yakir B., Risch N., Zak N.B., and Darvasi A. A highly significant association between a COMT haplotype and schizophrenia. Am. J. Hum. Genet. 71 (2002) 1296-1302
223. Shimizu E., Hashimoto K., Koizumi H., Kobayashi K., Itoh K., Mitsumori M., Ohgake S., Okamura N., Koike K., Matsuzawa D., Zhang L., Kumakiri C., Nakazato M., Komatsu N., and Iyo M. No association of the brain-derived neurotrophic factor (BDNF) gene polymorphisms with panic disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 29 (2005) 708-712
224. Shlik J., Vasar V., Aluoja A., Kingisepp P.H., Jagomagi K., Vasar E., Rago L., and Bradwejn J. The effect of cholecystokinin tetrapeptide on respiratory resistance in healthy volunteers. Biol. Psychiatry 42 (1997) 206-212
225. Shugart Y.Y., Samuels J., Willour V.L., Grados M.A., Greenberg B.D., Knowles J.A., McCracken J.T., Rauch S.L., Murphy D.L., Wang Y., Pinto A., Fyer A.J., Piacentini J., Pauls D.L., Cullen B., Page J., Rasmussen S.A., Bienvenu O.J., Hoehn-Saric R., Valle D., Liang K.Y., Riddle M.A., and Nestadt G. Genomewide linkage scan for obsessive-compulsive disorder: evidence for susceptibility loci on chromosomes 3q, 7p, 1q, 15q, and 6q. Mol. Psychiatry 11 (2006) 763-770
226. Skre I., Onstad S., Torgersen S., Lygren S., and Kringlen E. A twin study of DSM-III-R anxiety disorders. Acta Psychiatr. Scand. 88 (1993) 85-92
227. Skre I., Onstad S., Torgersen S., Philos D.R., Lygren S., and Kringlen E. The heritability of common phobic fear: a twin study of a clinical sample. J. Anxiety Disord. 14 (2000) 549-562
228. Stein B., Chartier J., Kozak M.V., King N., and Kennedy J.L. Genetic linkage to the serotonin transporter protein and 5HT2A receptor genes excluded in generalized social phobia. Psychiatry Res. 81 (1998) 283-291
229. Stein M.B., Chartier M.J., Hazen A.L., Kozak M.V., Tancer M.E., Lander S., Furer P., Chubaty D., and Walker J.R. A direct-interview family study of generalized social phobia. Am. J. Psychiatry 155 (1998) 90-97
230. Stein M.B., Fallin M.D., Schork N.J., and Gelernter J. COMT polymorphisms and anxiety-related personality traits. Neuropsychopharmacology 30 (2005) 2092-2102
231. Stein M.B., Jang K.L., Taylor S., Vernon P.A., and Livesley W.J. Genetic and environmental influences on trauma exposure and posttraumatic stress disorder symptoms: a twin study. Am. J. Psychiatry 159 (2002) 1675-1681
232. Stein M.B., Seedat S., and Gelernter J. Serotonin transporter gene promoter polymorphism predicts SSRI response in generalized social anxiety disorder. Psychopharmacology 187 (2006) 68-72
233. Steinlein O.K., Deckert J., Nothen M.M., Franke P., Maier W., Beckmann H., and Propping P. Neuronal nicotinic acetylcholine receptor alpha 4 subunit (CHRNA4) and panic disorder: an association study. Am. J. Med. Genet. 74 (1997) 199-201
234. Stevenson J., Batten N., and Cherner M. Fears and fearfulness in children and adolescents: a genetic analysis of twin data. J. Child Psychol. Psychiatry 33 (1992) 977-985
235. Tadic A., Rujescu D., Szegedi A., Giegling I., Singer P., Moller H.J., and Dahmen N. Association of a MAOA gene variant with generalized anxiety disorder, but not with panic disorder or major depression. Am. J. Med. Genet. B Neuropsychiatr. Genet. 117 (2003) 1-6
236. Taillon-Miller P., Saccone S.F., Saccone N.L., Duan S., Kloss E.F., Lovins E.G., Donaldson R., Phong A., Ha C., Flagstad L., Miller S., Drendel A., Lind D., Miller R.D., Rice J.P., and Kwok P.Y. Linkage disequilibrium maps constructed with common SNPs are useful for first-pass disease association screens. Genomics 84 (2004) 899-912
237. Tharmalingam S., King N., De L.V., Rothe C., Koszycki D., Bradwejn J., Macciardi F., and Kennedy J.L. Lack of association between the corticotrophin-releasing hormone receptor 2 gene and panic disorder. Psychiatr. Genet. 16 (2006) 93-97
238. Thomsen P.H. Obsessive-compulsive disorder in children and adolescents: a study of parental psychopathology and precipitating events in 20 consecutive Danish cases. Psychopathology 28 (1995) 161-167
239. Thorgeirsson T.E., Oskarsson H., Desnica N., Kostic J.P., Stefansson J.G., Kolbeinsson H., Lindal E., Gagunashvili N., Frigge M.L., Kong A., Stefansson K., and Gulcher J.R. Anxiety with panic disorder linked to chromosome 9q in Iceland. Am. J. Hum. Genet. 72 (2003) 1221-1230
240. Torgersen S. The nature and origin of common phobic fears. Br. J. Psychiatry 134 (1979) 343-351
241. Torgersen S. Genetic factors in anxiety disorders. Arch. Gen. Psychiatry 40 (1983) 1085-1089
242. Tot S., Erdal M.E., Yazici K., Yazici A.E., and Metin O. T102C and -1438 G/A polymorphisms of the 5-HT2A receptor gene in Turkish patients with obsessive-compulsive disorder. Eur. Psychiatry 18 (2003) 249-254
243. True W.R., Rice J., Eisen S.A., Heath A.C., Goldberg J., Lyons M.J., and Nowak J. A twin study of genetic and environmental contributions to liability for posttraumatic stress symptoms. Arch. Gen. Psychiatry 50 (1993) 257-264
244. Tsuang M., Domschke K., Jerskey B.A., and Lyons M.J. Agoraphobic behavior and panic attack: a study of male twins. J. Anxiety Disord. 18 (2004) 799-807
245. Urraca N., Camarena B., Gomez-Caudillo L., Esmer M.C., and Nicolini H. Mu opioid receptor gene as a candidate for the study of obsessive compulsive disorder with and without tics. Am. J. Med. Genet. B Neuropsychiatr. Genet. 127 (2004) 94-96
246. van Grootheest D.S., Cath D.C., Beekman A.T., and Boomsma D.I. Twin studies on obsessive-compulsive disorder: a review. Twin Res. Hum. Genet. 8 (2005) 450-458
247. Walitza S., Wewetzer C., Warnke A., Gerlach M., Geller F., Gerber G., Gorg T., Herpertz-Dahlmann B., Schulz E., Remschmidt H., Hebebrand J., and Hinney A. 5-HT2A promoter polymorphism -1438G/A in children and adolescents with obsessive-compulsive disorders. Mol. Psychiatry 7 (2002) 1054-1057
248. Wang A.G., Dahl H.A., Vang M., Als T.D., Ewald H., Kruse T.A., and Mors O. Genetics of panic disorder on the Faroe Islands: a replication study of chromosome 9 and panic disorder. Psychiatr. Genet. 16 (2006) 99-104
249. Wang Z., Valdes J., Noyes R., Zoega T., and Crowe R.R. Possible association of a cholecystokinin promoter polymorphism (CCK-36CT) with panic disorder. Am. J. Med. Genet. 81 (1998) 228-234
250. Weissman M.M., Wickramaratne P., Adams P.B., Lish J.D., Horwath E., Charney D., Woods S.W., Leeman E., and Frosch E. The relationship between panic disorder and major depression. A new family study. Arch. Gen. Psychiatry 50 (1993) 767-780
251. Willour V.L., Yao S.Y., Samuels J., Grados M., Cullen B., Bienvenu III O.J., Wang Y., Liang K.Y., Valle D., Hoehn-Saric R., Riddle M., and Nestadt G. Replication study supports evidence for linkage to 9p24 in obsessive-compulsive disorder. Am. J. Hum. Genet. 75 (2004) 508-513
252. Woo J.M., Yoon K.S., Choi Y.H., Oh K.S., Lee Y.S., and Yu B.H. The association between panic disorder and the L/L genotype of catechol-O-methyltransferase. J. Psychiatr. Res. 38 (2004) 365-370
253. Woo J.M., Yoon K.S., and Yu B.H. Catechol O-methyltransferase genetic polymorphism in panic disorder. Am. J. Psychiatry 159 (2002) 1785-1787
254. Wu S., and Comings D.E. A common C-1018G polymorphism in the human 5-HT1A receptor gene. Psychiatr. Genet. 9 (1999) 105-106
255. Yamada K., Hattori E., Shimizu M., Sugaya A., Shibuya H., and Yoshikawa T. Association studies of the cholecystokinin B receptor and A2a adenosine receptor genes in panic disorder. J. Neural Transm. 108 (2001) 837-848
256. Zai G., Arnold P., Burroughs E., Barr C.L., Richter M.A., and Kennedy J.L. Evidence for the gamma-amino-butyric acid type B receptor 1 (GABBR1) gene as a susceptibility factor in obsessive-compulsive disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 134 (2005) 25-29
257. Zai G., Arnold P.D., Burroughs E., Richter M.A., and Kennedy J.L. Tumor necrosis factor-alpha gene is not associated with obsessive-compulsive disorder. Psychiatr. Genet. 16 (2006) 43-45
258. Zai G., Bezchlibnyk Y.B., Richter M.A., Arnold P., Burroughs E., Barr C.L., and Kennedy J.L. Myelin oligodendrocyte glycoprotein (MOG) gene is associated with obsessive-compulsive disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 129 (2004) 64-68
259. Zhang H., Leckman J.F., Pauls D.L., Tsai C.P., Kidd K.K., and Campos M.R. Genomewide scan of hoarding in sib pairs in which both sibs have Gilles de la Tourette syndrome. Am. J. Hum. Genet. 70 (2002) 896-904
260. Zhang H., Ozbay F., Lappalainen J., Kranzler H.R., van Dyck C.H., Charney D.S., Price L.H., Southwick S., Yang B.Z., Rasmussen A., and Gelernter J. Brain derived neurotrophic factor (BDNF) gene variants and Alzheimer's disease, affective disorders, posttraumatic stress disorder, schizophrenia, and substance dependence. Am. J. Med. Genet. B Neuropsychiatr. Genet. 141 (2006) 387-393
261. Zhang X., Beaulieu J.M., Sotnikova T.D., Gainetdinov R.R., and Caron M.G. Tryptophan hydroxylase-2 controls brain serotonin synthesis. Science 305 (2004) 217